Omicron breakthrough infection significantly boosted S1- (1.1-fold increase) and S2-specific (1.2-fold increase) IgG and S1- (2.7-fold increase) and RBD-specific (3.5-fold increase) IgA responses. Here, CD79A is linked to infection.